PT - JOURNAL ARTICLE AU - Kechagias-Stamatis, Odysseas AU - Aouf, Nabil AU - Koukos, John A. TI - Deep Learning Fusion for COVID-19 Diagnosis AID - 10.1101/2020.12.11.20246546 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.11.20246546 4099 - http://medrxiv.org/content/early/2020/12/14/2020.12.11.20246546.short 4100 - http://medrxiv.org/content/early/2020/12/14/2020.12.11.20246546.full AB - The outbreak of the novel coronavirus (COVID-19) disease has spurred a tremendous research boost aiming at controlling it. Under this scope, deep learning techniques have received even more attention as an asset to automatically detect patients infected by COVID-19 and reduce the doctor’s burden to manually assess medical imagery. Thus, this work considers a deep learning architecture that fuses the layers of current-state-of-the-art deep networks to produce a new structure-fused deep network. The advantages of our deep network fusion scheme are multifold, and ultimately afford an appealing COVID-19 automatic diagnosis that outbalances current deep learning methods. Indeed, evaluation on Computer Tomography (CT) and X-ray imagery considering a two-class (COVID-19/ non-COVID-19) and a four-class (COVID-19/ non-COVID-19/ Pneumonia bacterial / Pneumonia virus) classification problem, highlights the classification capabilities of our method attaining 99.3% and 100%, respectively.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used are open-source